Quick Answer
Xtant Medical Holdings, Inc. reported Diluted EPS of $0.03 per share for fiscal year 2025.
Xtant Medical Holdings, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.03 | +125.0% |
| 2024 | -$0.12 | -1300.0% |
| 2023 | $0.01 | +111.1% |
| 2022 | -$0.09 | -50.0% |
| 2021 | -$0.06 | +76.0% |
| 2020 | -$0.25 | +60.3% |
| 2019 | -$0.63 | +89.4% |
| 2018 | -$5.97 | +82.8% |
| 2017 | -$34.76 | -2157.1% |
| 2016 | -$1.54 | -541.7% |
| 2015 | -$0.24 | +86.4% |
| 2014 | -$1.76 | +37.1% |
| 2013 | -$2.80 | -1455.6% |
| 2012 | -$0.18 | -125.0% |
| 2011 | -$0.08 | +86.9% |
| 2010 | -$0.61 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.01 | +125.0% | -50.0% |
| June 30, 2025 | $0.02 | +166.7% | — |
| March 31, 2025 | $0.00 | +100.0% | +100.0% |
| September 30, 2024 | -$0.04 | -157.1% | -33.3% |
| June 30, 2024 | -$0.03 | -50.0% | +0.0% |
| March 31, 2024 | -$0.03 | -50.0% | -142.9% |
| September 30, 2023 | $0.07 | +333.3% | +450.0% |
| June 30, 2023 | -$0.02 | +0.0% | +0.0% |
- Xtant Medical Holdings, Inc. showed an increase of +125.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2010–2025 period, Xtant Medical Holdings, Inc.’s diluted eps has grown by 104.9% (from $0.61 per share (loss) to $0.03 per share).
- The most recent figure is from Xtant Medical Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: